Corporate Disclosure2021
-
Dec. 17, 2021
Notice Concerning Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)
-
Dec. 17, 2021
Notice of Absorption-type Merger with Olympus Logitex, a Wholly Owned Subsidiary (Simplified and Short-form Merger)
-
Dec. 17, 2021
Notice Regarding Stock Repurchase
-
Nov. 05, 2021
(Progress of Disclosure Matters) Notice Concerning Commencement of Consideration on Intra-Group Reorganization of Scientific Solutions Business
-
Oct. 01, 2021
(Progress of Disclosure Matters) Notice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
-
Sep. 27, 2021
Notice Regarding Establishment of a Corporate Venture Capital Fund “Olympus Innovation Ventures”
-
Sep. 24, 2021
Notification with new appointment of the Executive Officers
-
Sep. 24, 2021
Notice Regarding Application for Selection of New Market Segment “Prime Market” on the Tokyo Stock Exchange
-
Jul. 21, 2021
Notice of Completion of Payment for Disposal of Treasury Shares as Post-Delivery Type Restricted Share-Based Compensation
-
Jul. 09, 2021
Notice Concerning Dismissal of the Appeal against the Consolidated Subsidiary (Sub-subsidiary)
-
Jun. 24, 2021
Notice of Disposal of Treasury Shares as Post-Delivery Type Restricted Share-Based Compensation
-
Jun. 17, 2021
(Change of Disclosure Matters) Notice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
-
Jun. 04, 2021
Notice Concerning Commencement of Consideration on Intra-Group Reorganization of Scientific Solutions Business
-
May. 28, 2021
(Progress of disclosure matters) Notice Regarding Completion of Acquisition of Israeli medical device company Medi-Tate Ltd. (new subsidiary)
-
May. 07, 2021
Notice Regarding Dividend of Retained Earnings
-
May. 07, 2021
Notice Regarding Cancellation of Treasury Stock
-
Apr. 30, 2021
(Change of Disclosure Matters) Notice Regarding start of the process to acquire Israeli medical device company Medi-Tate Ltd. (new subsidiary) pursuant to its call option rights
-
Apr. 30, 2021
Notice Concerning the Revision of Financial Forecast
-
Apr. 09, 2021
Notice Concerning Dismissal of the Lawsuit and Filing of Appeal against the Consolidated Subsidiary (Sub-subsidiary)
-
Apr. 06, 2021
Notice Concerning Termination of the Consolidated Subsidiary (Sub-subsidiary)’s Interventions in an Administrative Lawsuit
-
Mar. 12, 2021
Notice Concerning the Consolidated Subsidiary (Sub-subsidiary)’s Intervention in an Administrative Lawsuit
-
Feb. 26, 2021
Notice Regarding start of the process to acquire Israeli medical device company Medi-Tate Ltd. (new subsidiary) pursuant to its call option rights
-
Feb. 26, 2021
Notice Regarding Result of the Career Support for External Opportunity
-
Feb. 12, 2021
Notice Concerning Recording Other Expenses and the Revision of Financial Forecast
-
Feb. 12, 2021
Notification for the Candidate for the Board of Directors
-
Feb. 12, 2021
Notice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
-
Feb. 10, 2021
(Progress of disclosure matters) Notice regarding completion of acquisition of Quest Photonic Devices B.V. (to make it a subsidiary) in the Netherlands
-
Jan. 28, 2021
Notice regarding Acquisition of Quest Photonic Devices B.V. (to make it a subsidiary) in the Netherlands
-
Jan. 04, 2021
(Progress of Disclosure Matters) Notice Regarding Closing of Divestiture of Imaging Business
